229 related articles for article (PubMed ID: 1808338)
21. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
Eschbach JW; Haley NR; Adamson JW
Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
[No Abstract] [Full Text] [Related]
22. [Two new drugs. Recombinant "human" erythropoietin (EPO: Erypo, Recormon)].
Verwiebe R
Internist (Berl); 1992 Apr; 33(4):279-81. PubMed ID: 1612854
[No Abstract] [Full Text] [Related]
23. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
Müller R; Steffen HM; Brunner R; Saric J; Pollok M; Baldamus CA; Kaufmann W
Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
[TBL] [Abstract][Full Text] [Related]
24. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
[TBL] [Abstract][Full Text] [Related]
25. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
Nissenson AR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
[TBL] [Abstract][Full Text] [Related]
26. rHuEpo before dialysis and in dialysed patients.
López-Gómez JM; Jofre R; Moreno F; Verde E; Valderràbano F
Nephrol Dial Transplant; 1995; 10 Suppl 6():31-5. PubMed ID: 8524491
[No Abstract] [Full Text] [Related]
27. [Cutaneous reactions to treatment with recombinant human erythropoietin].
Schröder-Kolb B
Derm Beruf Umwelt; 1990; 38(1):12-3. PubMed ID: 2139602
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.
Schwartz AB; Prior JE; Mintz GS; Kim KE; Kahn SB
Transplant Proc; 1991 Apr; 23(2):1827-30. PubMed ID: 2053168
[TBL] [Abstract][Full Text] [Related]
29. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
[TBL] [Abstract][Full Text] [Related]
30. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
Marisavljević D; Djukanović Lj; Lezajić V
Srp Arh Celok Lek; 1992; 120(9-10):281-5. PubMed ID: 1306020
[TBL] [Abstract][Full Text] [Related]
31. [Disordered alpha 2-adrenoreceptor function in hemodialysis patients with renal anemia--a possible cause of increased blood pressure in relation to recombinant human erythropoietin?].
Müller R; Steffen HM; Brunner R; Pollok M; Baldamus CA; Kaufmann W
Klin Wochenschr; 1991 Oct; 69(16):742-8. PubMed ID: 1662322
[TBL] [Abstract][Full Text] [Related]
32. [Countermeasure for patients with anemia due to hemodialysis].
Suzuki M
Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1663-7. PubMed ID: 8537721
[No Abstract] [Full Text] [Related]
33. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
Chu JQ
Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758
[No Abstract] [Full Text] [Related]
34. [Erythropoietin].
Uhl D
Med Monatsschr Pharm; 1990 May; 13(5):130-1. PubMed ID: 2192242
[No Abstract] [Full Text] [Related]
35. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
Wiecek A
Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
[No Abstract] [Full Text] [Related]
36. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure].
Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371
[TBL] [Abstract][Full Text] [Related]
37. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
von Appen K; Klinkmann H
Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
[No Abstract] [Full Text] [Related]
38. [The relationship between anemia and blood pressure in chronic hemodialysis patients--studies of hemodynamics].
Shitomi K; Ozawa Y; Takada K; Maeda T; Kaneda H
Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):67-72. PubMed ID: 3386012
[No Abstract] [Full Text] [Related]
39. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
[No Abstract] [Full Text] [Related]
40. Impact of erythropoietin on the dialysis prescription.
Van Wyck DB
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
